The top 5 studies from June 2019

July 2, 2019

Ranging from biomarkers that can define PTB risk to the impact of age and fertility, these are five of the most noteworthy studies published in June 2019.

Benzodiazepines and spontaneous abortion

A new study from JAMA Psychiatry examines if all benzodiazepines, regardless of drug or duration of action, carry the same risk of spontaneous abortion.

©Cappi Thompson - stock.adobe.com

PTB

Results from a recent study published in Nature Medicine hold promise for development of biomarkers that could be used to define risk of PTB in African-American women.

©Adele De Witte - stock.adobe.com

Test for Zika

For the first time, the US Food and Drug Administration (FDA) has authorized marketing of a test to detect Zika virus immunoglobulin (IgM) antibodies in the bloodstream.

Syncope and pregnancy

New research from The Journal of the American Heart Association illustrates why it's important for ob/gyns to discuss syncope history with their pregnant patients.

Age and fertility

A new study published in the Journal of Women's Health indicates that millions of women may not realize the impact age has on fertility due to coverage of celebrity pregnancies in consumer magazines.